13F

Stock

Protagonist Therapeutics, Inc

PTGX · held by 11 managers

Reported value

$700.7M

Holders

11

+1 new · −0 exited

Holders’ est. mark

$2.58M

Price effect on 2 books still in the name

Largest holder

$411.6M

FARALLON CAPITAL MANAGEMENT LLC

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
FARALLON CAPITAL MANAGEMENT LLC6.2M$411.6MNew
JOHNSON & JOHNSON2.45M$162.7MHeld
BANK OF AMERICA CORP /DE/829.9K$55.1MHeld
MORGAN STANLEY768.4K$51MHeld
BARCLAYS PLC171.4K$11.4M$1.91MCut−$336.9K
Boxer Capital Management, LLC110K$7.31M$669.6KAdded$3.99M
Persistent Asset Partners Ltd11.8K$782.5KHeld
Cambria Investment Management, L.P.10.9K$727KHeld
Allworth Financial LP247$16.4KHeld
Kilter Group LLC4$266Held
KBC Group NV1.57K$105Held

Positions as of Q3 2025. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.